MedPath

To evaluate the Safety and efficacy of Unani formulations in the treatment of Dysentery

Phase 2
Recruiting
Conditions
Acute amebic dysentery, DYSENTRY,
Registration Number
CTRI/2013/12/004262
Lead Sponsor
Monetary Support Central Council for Research in Unani Medicine CCRUM New Delhi
Brief Summary

This study is designed as a multicentric open trial in patients with **Zaheer(Dysentry).** After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria.  The clinical follow-up will be carried out every alternate day.This includes subjective assessment of general well being and physical examination. The total duration of treatment will be 01 week. Laboratory parameters for safety assessment will be conducted at baseline and end of study.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
170
Inclusion Criteria

•Age-20-60 •Increased frequency of motion •Tenesmus •Sense of incomplete evacuation •Frequent constipation followed by diarrhoea •Loose stools with or without mucous •Associated symptoms like Nausea /Flatulence /Vomiting.

Exclusion Criteria

1Patients with severe loose motion more than 8 in a day 2Patients with blood in stool 3Cholera/Ulcerative colitis 4High grade fever (more than 101 ºC) 5Patient having illnesses requiring long term treatment especially DM, CRF,HT.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in signs and symptoms1 WEEK
Secondary Outcome Measures
NameTimeMethod
Hematological and biochemical assessments for safety1 WEEK

Trial Locations

Locations (2)

CLINICAL RESEARCH UNIT

🇮🇳

Meerut, UTTAR PRADESH, India

Regional Research Institute of Unani Medicine, New Delhi

🇮🇳

South, DELHI, India

CLINICAL RESEARCH UNIT
🇮🇳Meerut, UTTAR PRADESH, India
DR MOHD TARIQ KHAN
Principal investigator
09012843253
doctormtk@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.